Core Scientific upgraded on its uncontracted power capacity
الأصول والمواضيع المتأثرة
لماذا يهم
التحليل معروض بالإنجليزية · الترجمة العربية قيد الإعداد
Roth MKM upgraded Core Scientific to Buy, expecting the merger with CoreWeave to be rejected without renegotiation, citing growing shareholder opposition and proxy advisers' recommendations against the deal.
نبرة المقال
التأثير المتوقع على السوق
Positive, as the upgrade and increased price target of $23.50 may lead to a short-term increase in Core Scientific's stock price, potentially benefiting investors who hold the stock.
مسار الأدلة
الأدلة
مصدر التحليل بالذكاء الاصطناعي
المعرّفات التقنية
- وسم المزوّد
- groq-llama-3.1-8b-instant
- إصدار التحليل
- groq-llama-3.1-8b-instant
- معرّف المقال
- 1597
المصدر الأصلي
Investing.com --Roth MKM upgraded Core Scientific to Buy saying it now expects the data center operator’s merger with CoreWeave to be rejected without renegotiation and sees value in its uncontracted power capacity.Roth lifted its price target to $23.50 from $17. There is growing shareholder opposition against deal and CoreWeave’s insistence that its offer was “best and final” have made the deal unlikely to close. Proxy advisers Glass Lewis and ISS have also recommended against it. The firms are
اقرأ المقال كاملاً على Yahoo Finance
المقال الأصلي منشور بواسطة Yahoo Finance في أكتوبر 23, 2025. التحليل والرؤى المقدمة من AnalystMarkets AI.